Document Detail


Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes.
MedLine Citation:
PMID:  20978346     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mutations in pancreatic duodenal homeobox (PDX1) are linked to human type 2 diabetes and maturity-onset diabetes of the young type 4. Consistent with this, Pdx1-haploinsufficient mice develop diabetes. Both apoptosis and necrosis of β cells are mechanistically implicated in diabetes in these mice, but a molecular link between Pdx1 and these 2 forms of cell death has not been defined. In this study, we introduced an shRNA into mouse insulinoma MIN6 cells to deplete Pdx1 and found that expression of proapoptotic genes, including NIP3-like protein X (Nix), was increased. Forced Nix expression in MIN6 and pancreatic islet β cells induced programmed cell death by simultaneously activating apoptotic and mitochondrial permeability transition-dependent necrotic pathways. Preventing Nix upregulation during Pdx1 suppression abrogated apoptotic and necrotic β cell death in vitro. In Pdx1-haploinsufficient mice, Nix ablation normalized pancreatic islet architecture, β cell mass, and insulin secretion and eliminated reactive hyperglycemia after glucose challenge. These results establish Nix as a critical mediator of β cell apoptosis and programmed necrosis in Pdx1-deficient diabetes.
Authors:
Kei Fujimoto; Eric L Ford; Hung Tran; Burton M Wice; Seth D Crosby; Gerald W Dorn; Kenneth S Polonsky
Related Documents :
18793156 - Lipases in the pancreatic beta-cell: implications for insulin secretion.
9267986 - Impaired development of pancreatic beta-cell mass is a primary event during the progres...
19607676 - Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes ...
16185166 - Investigational agents that protect pancreatic islet beta-cells from failure.
16772206 - Is exenatide a useful addition to diabetes therapy?
2714056 - Glucose enzyme electrode with percutaneous interface which operates independently of di...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-10-11
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  120     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-02     Completed Date:  2010-12-07     Revised Date:  2012-04-10    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4031-9     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / physiology*
Cell Line, Tumor
Diabetes Mellitus, Type 2 / metabolism*
Gene Expression Profiling
Glucose / metabolism
Homeodomain Proteins / genetics,  metabolism*
Humans
Insulin-Secreting Cells / cytology,  metabolism*,  pathology*
Membrane Proteins / genetics,  metabolism*
Mice
Mice, Knockout
Microarray Analysis
Mitochondrial Proteins / genetics,  metabolism*
Necrosis*
Trans-Activators / genetics,  metabolism*
Grant Support
ID/Acronym/Agency:
P30 DK052574/DK/NIDDK NIH HHS; P60 DK-20579/DK/NIDDK NIH HHS; R01 DK031842/DK/NIDDK NIH HHS; R01 HL059888/HL/NHLBI NIH HHS; R01 HL059888-12/HL/NHLBI NIH HHS; R01 HL059888-13/HL/NHLBI NIH HHS; UL1 RR024992/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Homeodomain Proteins; 0/Membrane Proteins; 0/Mitochondrial Proteins; 0/Nix protein, mouse; 0/Trans-Activators; 0/pancreatic and duodenal homeobox 1 protein; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice...
Next Document:  Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascula...